Weight loss, diabetes drugs can cause mood changes: What to know about behavioral side effects
Some examples of these medications include semaglutides, such as Ozempic and Wegovy, and liraglutide, like Victoza and Saxenda.
Advertisement
Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression.
The National Institutes of Health (NIH) published research in June 2024 that considered the correlation between semaglutide therapy and 'exacerbating mood disturbances.'
The study highlighted the association of negative mood changes in patients with type 2 diabetes with a history of depression, warning healthcare providers to be aware of this 'potential risk.'
But a more recent study, published in the journal Diabetes, Obesity and Metabolism, suggested that these mood changes were linked to genetic variations across diverse populations and ancestries within the U.K. Biobank.
Advertisement
While GLP-1 RA variants had 'consistent cardiometabolic effects' across all groups, the researchers said the negative impacts on mental health were 'more varied,' concluding that any behavioral changes are 'likely not acting directly through [the medications].'
5 Nazario noted that GLP-1 RAs can affect mood in many different ways.
tmc_photos – stock.adobe.com
Doctors weigh in on medications and mood
Dr. Brett Osborn, a Florida neurosurgeon who often prescribes GLP-1 RAs to his patients, believes that there is 'no consistent causal relationship' between these medications and mental illness.
'Researchers assayed genetic markers across almost half a million people from different backgrounds in search of a link between the gene behind GLP-1 receptors and mental health problems like depression, anxiety or suicidal ideation — and they didn't find it,' he summarized.
Advertisement
People who are obese or battling type 2 diabetes are 'often already depressed' without the medication, the doctor pointed out.
5 Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression.
nazif – stock.adobe.com
'These conditions take a toll – physically, emotionally and socially,' he said. 'So, yes, a large portion of patients starting GLP-1 drugs are already dealing with mental health struggles. But that's not because of the drug — that's because of the disease.'
Once these individuals begin dropping weight, blood sugar stabilizes and energy improves, which usually lifts their mood as well.
Advertisement
'GLP-1 drugs help people reclaim their health,' Osborn noted. 'They reduce inflammation. They lower blood sugar. They shrink waistlines.'
5 People who are obese or battling type 2 diabetes are 'often already depressed' without the medication, the doctor pointed out.
K KStock – stock.adobe.com
'And when people look and feel better, when their bodies finally start working for them instead of against them, they often smile more, not less.'
Dr. Muhammad Ghanem, a bariatric surgeon at Orlando Health Weight Loss and Bariatric Surgery Institute, shared in a separate interview with Fox News Digital that while some of his patients have reported mood changes, others 'don't have that at all.'
'Depression or mood changes are very common regardless, especially nowadays, and so it's hard to [determine] whether this is related to the GLP-1 agonist medications, or whether it just happens to be that they started suffering from these after they started that medication,' he said.
'It's really hard to tell whether it's a personality change that can happen because of weight loss or if it's a side effect because of mood changes,' he added. 'I don't think we have enough data to reach that conclusion yet.'
Patients who lose weight with GLP-1 RAs can experience a 'big boost' in confidence, as well as a change in personality and even relationships, according to Ghanem.
5 Once these individuals begin dropping weight, blood sugar stabilizes and energy improves, which usually lifts their mood as well.
Tinnakorn – stock.adobe.com
Advertisement
'It really depends on the person and the support system they have,' he said. 'You need proper, randomized controlled trials to reach a conclusion, and better studies to determine whether this is related to the medication itself or just weight loss.'
'It's important for all doctors who prescribe these drugs to be aware and check the patient's history.'
For those who are interested in these medications or are experiencing mood changes while taking them, the surgeon stressed the importance of keeping in close contact with medical providers.
'Just like any other medication, they can have potential side effects,' he said.
Advertisement
Ghanem recommended seeking out professionals and practices who take a 'holistic approach' to weight loss, offering mental health support in addition to medication.
5 For those who are interested in these medications or are experiencing mood changes while taking them, the surgeon stressed the importance of keeping in close contact with medical providers.
alones – stock.adobe.com
Dr. Brunilda Nazario, MD, chief physician editor of medical affairs at WebMD, told Fox News Digital that 'obesity is complicated.'
'Obesity specialists … are cautiously excited about how well these drugs work,' she said.
Advertisement
'With current studies showing conflicting results on mood disorders and the use of GLP-1 drugs, it's important for all doctors who prescribe these drugs to be aware and check the patient's history before prescribing [them].'
Nazario stressed that it's 'vital' for GLP-1 RA users to listen to their bodies, urging them to pay attention to their feelings and know the symptoms of mood disorders.
'Don't be afraid to ask for help if you feel something is not right — your health depends on it,' he added.
Advertisement
Nazario noted that GLP-1 RAs can affect mood in many different ways.
'They are not all negative — they have the potential to improve mood as well,' she said. 'Just seeing great results can boost self-esteem, confidence and body image.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fast Company
4 hours ago
- Fast Company
Women are being erased from medical research—again
When we started Equal Research Day on June 10, 2022—the anniversary of women finally being included in U.S. clinical research in 1993—we intended it to be a celebration of progress and a call for more inclusive science. We wanted to mark how far we'd come and how much opportunity still lay ahead. We never imagined that just three years later, we'd be fighting to keep that progress from being undone. The Trump administration's ongoing federal actions targeting women, diversity, and equity—such as budget cuts affecting critical research funding, and the sporadic erasure of critical data and education—have already caused massive damage and hindered progress for health parity in only five short months. We're just beginning to wrap our minds around the lost progress and bleak future that we're facing if there is no change of course. And we don't have time, let alone four years, to wait on continuing health parity work—for women and for all marginalized groups harmed by the administration's actions. If it feels like we are going back in time, it's because we are. As founders building the future of women's health, we can't stay quiet. We are witnessing the erasure of women —again. Medicine's long history of leaving women behind While women weren't required to be included in clinical research until 1993, the National Institutes of Health (NIH) didn't required researchers to account for sex as a biological variable until 2016. While some progress has been made, even in 2024 we were far from closing the research gap—particularly for marginalized and underrepresented groups. Because women have been left out of research for so long, many of the drugs, diagnostics, and standards of care we rely on today were never tested on women's bodies. As a result, women are diagnosed, on average, four years later than men across hundreds of diseases. Women are more likely to die in surgery if their surgeon is a man, and women are twice as likely to die after a heart attack, compared to men. We're more likely to be misdiagnosed, to experience severe medication side effects, and to be told our symptoms are 'all in our heads.' Behind already, we're taking massive steps backwards in closing the gender health gap and reaching health equity. In 2025, history is repeating itself This year alone, the NIH slashed $2.6 billion in contracts, plus an additional $9.5 billion for research grants, a devastating blow to women's health research. The Women's Health Initiative (WHI)—a decades-long study of 160,000 women, critical for better understanding chronic disease, hormone therapy, and more— was abruptly defunded in April (an apparent reversal to the cut was later confirmed in May), leaving the WHI in limbo for weeks. The Centers for Disease Control (CDC) fired 18% of its staff, including entire teams dedicated to maternal health, contraceptive guidance, and drug-resistant sexually transmitted infection (STI) tracking. And the National Science Foundation (NSF) canceled over 1,400 grants, especially those tied to gender, equity, or health disparities. Federal agencies were given directives to reject funding for any research grants that include 'banned words' such as 'women, trans, or diversity,' at the NIH, and for the NSF, an even longer list, including: -'Female' and 'women,' but not male or men -'Male dominated' -'Gender' -'Equity' -'Diversity' -'Minority' -'Underrepresented' -'Antiracist' -'Diversity' -'Trauma' -'Biases' -'Disability' -'Inclusion' -'Victims' -'Racially' This is targeted, strategic, and deeply dangerous for not only women, but for all underserved and under-researched groups that need the funding and research the most. Data and education are disappearing, too As if defunding wasn't enough, the federal government scrubbed over 8,000 public health web pages. These included critical health guidance on contraception, LGBTQ+ health, STIs, and maternal outcomes. Some of the pages were hastily scrubbed and restored while missing key facts, essentially erasing certain groups. The CDC removed or changed key datasets and web pages on the LGBTQ+ community and other underrepresented, marginalized groups. The CDC also pulled fact sheets on HIV prevention, HIV diagnosis, and transmission, and then republished some of the information, leaving out transgender people. The FDA also took down an entire website dedicated to minority health and health equity. This kind of censorship isn't just alarming—it's life-threatening. If we can't see the data, we can't measure the problem. And if we can't measure the problem, we can't fix it. This is more than a research crisis. It's a public health emergency, and it will hit the most vulnerable communities the hardest. The U.S. has the highest maternal mortality rate of any wealthy nation. Erasing programs like PRAMS –which monitors postpartum complications, means entire states are now totally unequipped to track what happens to postpartum women. Shuttering research labs and programs on STIs, HIV, and sexual health will hinder progress for women's sexual health and disease prevention, particularly for women and LGBTQ communities. Finally, widespread government directives to cut research funding for anyone who focuses on gender threaten to undo all the progress we've made since 1993, and this in turn, hinders what we can change moving forward. We know that when women are under-researched, we pay the highest price. Women already spend 25% more of their lives in worse health than men. And, 64% of common medical interventions are less effective or less accessible for women, compared to only 10% for men. For every woman diagnosed with a women's health issue, approximately four are not diagnosed. (There are 97 similar statistics published in our book, 100 Effed Facts About The Gender Health Gap.) This will only get worse with the current federal actions. What can be done While some companies and researchers are stepping in to fill the void, in reality, no private innovation can replace the scale, accountability, and public good of federally funded research. As founders of a women's health company, we believe more than anyone about the power of private, high-growth solutions for the world's most pressing problems. We are doing our part at Evvy. But even we don't see the path through without government investment. Alone, we simply can't approach the scope and magnitude of what the government to help the more than 50% of the population who deserve better. Startups can pilot new tools, but they can't collect longitudinal data on maternal mortality across all 50 states. Academic labs can push science forward, but they can't maintain national health surveillance systems. The erosion of public health infrastructure means we're losing the connective tissue that links discovery to care. And without it, even the best innovations risk being isolated solutions in a broken system. This isn't just about research; it's about rights. It's about refusing to let an entire half of the population be sidelined under the excuse of cost cutting. We need to fund the science that sees us, protect the data that tells our stories, and build a healthcare system where women's bodies are studied, understood, and prioritized. We can fight for funding, for research, for truth. And, most importantly, we can fight to make sure women are never again an afterthought in the story of medicine. To help, join the Equal Research Day campaign to demand equal research funding for women, or donate to nonprofits funding critical research like Women's Health Access Matters and the Foundation for Women's Health. Priyanka Jain is CEO and cofounder of Evvy.
NBC News
6 hours ago
- NBC News
Liver cancer cases are projected to double, but more than half could be preventable
At least 60% of liver cancers could be preventable, according to an analysis published Monday in The Lancet. Liver cancer is the sixth most common cancer in the world, with around 870,000 cases in 2022. That's projected to increase to 1.52 million cases in 2050, the new report found, if no changes are made. The leading cause of liver cancer is viral infections, including the hepatitis B and C viruses. Hepatitis B infections — which are preventable with a vaccine — accounted for 39% of liver cancers in 2022. That's expected to fall slightly, to 36.9%, by 2025. Hepatitis C accounted for 29.1% of liver cancers in 2022 and is also projected to fall, to 25.9%, by 2050. The proportions of alcohol- and obesity-related liver cancers, however, are projected to rise in the next 25 years. Alcohol accounted for 18.8% of liver cancers in 2022, and that is expected to increase to 21.1% in 2050. The share of liver cancers caused by obesity-related disease is projected to increase from 8% to 10.8% by 2050 due to increasing rates of obesity, diabetes and high cholesterol and other metabolic risk factors. Dr. Hashem El-Serag, one of the report's co-authors and chair of the department of medicine at the Baylor College of Medicine in Houston, said the public usually thinks of alcohol as the biggest risk factor for liver cancer. 'I think for most people, if you say cirrhosis, they immediately think of a relative, of someone who was a heavy drinker,' El-Serag said. 'I think the vast majority do not make the tie between MASLD, or fatty liver, and cirrhosis and liver cancer.' MASLD, or metabolic dysfunction-associated steatotic liver disease, affects about 25% of adults in the U.S. It's caused by a buildup of fat in the liver. About 5% of U.S. adults have a more severe form, called metabolic dysfunction-associated steatohepatitis (MASH), which can lead to scarring, or cirrhosis, of the liver, significantly increasing the risk of cancer. Excess alcohol consumption can also lead to cirrhosis. Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report estimated that by 2040, U.S. rates of MASLD could more than double, affecting more than 55% of adults. Detecting liver cancer risk factors Earlier detection and effective treatment plans for MASLD can reduce the risk of obesity-related liver cancer, El-Serag said. The most common treatment is weight loss. GLP-1 weight loss drugs, which include Ozempic and Wegovy, are promising, he said. (A clinical trial published in April found that Wegovy treated MASH in about two-thirds of patients.) However, people aren't screened for MASLD like they are for viral hepatitis, El-Serag said. Dr. Arun Jesudian, a hepatologist and the director of liver quality and inpatient liver services at Weill Cornell Medicine and NewYork-Presbyterian, said patients are tested for MASLD and/or MASH if they have elevated liver enzymes in their blood. Raising awareness about MASLD among both patients and doctors can lead to more effective testing and diagnosis, Jesudian said. 'I think then we need to make sure that providers who are interacting with these patients are looking at the liver disease component of metabolic syndrome,' he said, referring to patients with a cluster of conditions including high blood sugar, high blood pressure and excess weight. 'So checking liver enzymes, that they know how to assess for fibrosis, even based on these blood test scores.' MASLD and MASH can often be asymptomatic, making self-detection more challenging. 'Right now, it's haphazard. Some people get tested. Others get suspected. Third, who knows?' El-Serag said. Dr. Neehar Parikh, a hepatologist at the University of Michigan who specializes in liver cancer, said he is seeing more patients with MASLD as a driving factor for liver cancer. Patients with MASLD can develop liver cancer without developing cirrhosis, making it even more challenging to detect those cases, Parikh said. Up to 40% of those with liver cancers linked to MASLD don't develop cirrhosis, according to the report. Figuring out who those patients are is the 'million-dollar question,' he said. 'Those patients that develop MASLD that develop liver cancer, you know, how do you screen that population? We don't really know what to do.' Still, Parikh said these types of cases are rare.
New York Post
9 hours ago
- New York Post
Be careful where you use this ‘colonic sweep' hack — doctor warns you might poop right away
Backed up? Dr. Jennale, a primary care doctor with over 275,000 followers on TikTok, recently shared a video that can help get things moving — but, fair warning, she cautions that the trick is dangerously effective. 'Be careful where you use this because you might poop right away or within 30 minutes,' she says. Advertisement Dr. Jennale recently shared a video that can help get things moving — but, fair warning, she cautions that the trick is dangerously effective. TikTok/@ It's called the 'colonic sweep' and it involves pressing and pushing along your lower abdomen in specific directions to mimic the natural movement of poop through your digestive system. The maneuver helps guide stool along the transverse and descending colon, following the path of peristalsis — the wave-like muscle contractions that move waste along. It's a hands-on approach to constipation relief that requires no laxatives — just fingers and finesse. Advertisement To do it, Le recommends first 'opening the outlet' by pressing into the lower left abdomen and pushing down toward the pelvis. Then, she advises moving to the transverse colon area — which is just under the ribs — and repeating the process. The motion is meant to work with, not against, the colon's natural shape and the mesentery — a fold of tissue that holds the intestines in place. Advertisement It's called the 'colonic sweep' and it involves pressing and pushing along your lower abdomen in specific directions to mimic the natural movement of poop through your digestive system. comzeal – In short: The right moves can help you go. The wrong ones could leave you bloated and backed up. Viewers were quick to praise this oddly effective method for relief. 'I learned to do this years ago whenever I feel really bloated,' one wrote. 'Works like a charm most times.' Advertisement @ Replying to @rlroshy colonic sweep. We are following the anatomy! I would make sure there's a washroom nearby ♬ original sound – Jenny | FM Physician Some might even call it magical. 'I did that to my ex once and he went so much, he called me a witch,' another wrote. 'This did, in fact, work within 30 min,' was another matter-of-fact response. Other poop hacks, courtesy of the internet, include taking an 'internal shower' by mixing chia seeds with water, letting them soak for about 20 minutes until they get their gel-like coating and drinking them. Travel nurse Brooke Saprito shared her secret recipe for the Hot Buttered Prune — a heated mixture of butter and prunes than can help move things along. And UK surgeon Dr. Karan Raj suggests sitting on the toilet with one leg crossed over the other to clear up any traffic in your colon. Advertisement An estimated 16% of American adults — and up to one-third of those over 60 — regularly suffer from constipation. It's often caused by a low-fiber diet, dehydration, lack of exercise or certain medications, according to the National Institutes of Health.
